Skip over global navigation links
U.S. Department of Health and Human Services
  • From the ASPR Blog: BARDA Supports a Rapid, Deployable, Sensitive Diagnostic Platform to Diagnose Anthrax

    BARDA awards Tangen BioSciences, Inc. a base-period contract to further advance & expand the ability to combat the threat of anthrax. If approved, the diagnostic test could be used to quickly determine if a symptomatic patient has been infected.


    anthrax virus 

PHE Newsroom

Submit an Inquiry


Watch, Listen, Subscribe

Facebook Exit Icon Twitter Exit Icon YouTube Exit Icon
Email via GovDelivery Exit Icon LinkedIn Exit Icon

  • This page last reviewed: December 07, 2017